Centre Of Eand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Centre of eand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Centre Of Eand Today - Breaking & Trending Today

Neoadjuvant/Adjuvant Pembrolizumab Regimen Continues to Show EFS Benefit in High-Risk Early TNBC

The 5-year event-free survival EFS) rate was 81.3% with neoadjuvant pembrolizumab/chemotherapy followed by adjuvant pembrolizumab compared with 72.3% in those who received placebo/chemotherapy plus placebo. ....

San Antonio , United States , Peter Schmid , Barts Breast Cancer Centre , Eastern Cooperative Oncology Group , Centre Of Eand , Oncology Nursing , Antonio Breast Cancer , Cancer Medicine , Antonio Breast Cancer Symposium , Event Free Survival , Triple Negative Breast Cancer , High Risk , Early Stage Triple Negative Breast Cancer , Keynote 522 , Neoadjuvant Pembrolizumab ,